FEATURED NEWS
NEWS: VERVE THERAPEUTICS ANNOUNCES HUMAN PROOF-OF-CONCEPT DATA FOR VERVE-101
Congratulations to our partner Verve for the newly released positive results from their VERVE-101 heart-1 phase 1b clinical trial. VERVE-101 uses our proprietary best-in-class LNP delivery system. Click for more info.
NEWS: ACUITAS APPOINTS DR. GHANIA CHIKH AS SENIOR DIRECTOR, VACCINE DEVELOPMENT (NOV 2023)
Dr. Ghania Chikh has been appointed Senior Director, Vaccine Development for Acuitas. With decades of experience in drug development, she will oversee the vaccine development program – working with Acuitas’ global partners. Click for more info.
NEWS: ALLIANCE FOR MRNA MEDICINES LAUNCHES (NOV 2023)
The Alliance for mRNA Medicines (AMM) launched on Nov 1 at the International mRNA Health Conference. We’re proud to support the AMM – the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines to benefit patients, public health and society. Click for more info.